Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FR8QZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,550
Award facts
- Contract value 100% obligated
- $18,549.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order valued at $18,549.82 from the Defense Logistics Agency (DLA) on November 18, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This is a firm fixed price, non-competitive delivery order with a completion date of November 19, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was competitively selected as a prime contractor for the DLA's pharmaceutical supply chain. The company's role encompasses the distribution of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. ENBREL is a branded biopharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions, making this delivery order representative of the company's ongoing commitment to supplying specialized medications for military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FR8QZ?
SPE2DR26FR8QZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FR8QZ worth?
The government has obligated $18,550 on SPE2DR26FR8QZ.
Is contract SPE2DR26FR8QZ an order under another contract?
Yes. SPE2DR26FR8QZ is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8QZ competed?
The extent of competition for SPE2DR26FR8QZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award